Our awards
PwC named a Leader in the IDC MarketScape: Worldwide Life Science R&D Strategic Consulting Services
PwC has been named a Leader in the IDC MarketScape: Worldwide Life Science R&D Strategic Consulting Services 2023 Vendor Assessment.
Commenting on PwC, the IDC MarketScape report states, ‘PwC brings deep, life sciences industry-specific expertise to engagements to focus on value creation and drive business transformation, design portfolio strategy, and innovation by leveraging its advisory services and digital assets. It improves patient outcomes and engagement through digital technologies and decentralized trials, drives productivity gains, shortens clinical trial execution timelines by optimizing clinical trial design, and improves engagement across the healthcare ecosystem.’
On PwC’s strengths, the report says, ‘Its key differentiators include its integrated transformation, cloud, digital, and managed services crossplatform strategy focused on innovation, its multidisciplinary team, which provides a unified approach across business process analysis and design, software development life cycle (SDLC) documentation and testing, and change management and training, and last, its expertise in ICH E6-compliant vendor oversight, quality management, and quality by design.’
PwC named a Leader in the IDC MarketScape: Worldwide Life Science Sales and Marketing Consulting
PwC has been named as a Leader in the IDC MarketScape: Worldwide Life Science Sales and Marketing Strategic Consulting Services 2023 Vendor Assessment.
The IDC MarketScape report notes, “PwC's strategic consulting practice in life sciences emphasizes evaluation and development of commercial models, partnering, data management, and rationalization. Consulting engagements include integrated digital health solutions, SFA, CRM, marketing analytics, cloud strategy, brand and launch management, multichannel marketing optimization, regulatory compliance, pricing and contracting, gross to net, digital therapeutics, and integrated biomarkers and diagnostics, among others.”
PwC China received 2022 Outstanding Partner award
PwC China was honoured with the 2022 Outstanding Partner award at this year’s Healthcare Technology Innovation Forum organised by Shanghai Services Federation Medical Services Professional Committee. Jingyu Cai, Strategy& Pharma and Healthcare Industry Partner, attended this event as one of the keynote speakers to discuss technology innovation and achievement transformation.
